Imiquimod
NDC Package 0093-6126-64

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Imiquimod is a medication used to treat certain types of growths on the skin. Marketed by Teva Pharmaceuticals Usa Inc, this product is identified by NDC 0093-6126 and is authorized under FDA application ANDA200481.

Identification & Billing

NDC Package Code
0093-6126-64
Package Description
24 PACKET in 1 CARTON / .25 g in 1 PACKET (0093-6126-19)
Product Code
0093-6126
11-Digit Billing Format
00093612664
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Imiquimod
Dosage Form
-
Usage Information
This medication is used to treat certain types of growths on the skin. These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor.

Regulatory & Marketing

Labeler Name
Teva Pharmaceuticals Usa Inc
FDA Application #
ANDA200481
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-19-2013
End Marketing Date
04-30-2015
Listing Expiration
04-30-2015
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0093-6126-64 identifies a specific commercial package of 24 packet in 1 carton / .25 g in 1 packet (0093-6126-19) of Imiquimod, labeled by Teva Pharmaceuticals Usa Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teva Pharmaceuticals Usa Inc on December 19, 2013. The current certification is valid through April 30, 2015.

What are the primary indications for this medication?

This medication is used to treat certain types of growths on the skin. These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor.

How is this Teva Pharmaceuticals Usa Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00093612664. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0093-6126-64
11-Digit CMS (5-4-2)
00093-6126-64

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.